Effects of glucocorticoid receptor small interfering RNA delivered using poly lactic-co-glycolic acid microparticles on proliferation and differentiation capabilities of human mesenchymal stromal cells

Tissue Engineering - Part A

Volumn 18, Issue 7-8, 2012, Pages 775-784

  Hong, Liu ^a   Wei, Na ^a   Joshi, Vijaya ^b   Yu, Yang ^a   Kim, Najung ^c   Krishnamachari, Yogita ^b   Zhang, Qiang ^d   Salem, Aliasger K ^b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c University of Iowa   (United States)

^d Nanfang Medical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; PHOSPHATASES; STEM CELLS; TISSUE;

ADIPOGENIC; ALKALINE PHOSPHATASE; BINDING FACTORS; BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; CELL-BASED; CLINICAL APPLICATION; DELIVERY SYSTEMS; FIBROBLAST GROWTH FACTOR-2; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOIDS; IN-VITRO; LIPOPROTEIN LIPASE; MESENCHYMAL STROMAL CELLS; MICRO-PARTICLES; OSTEOGENIC; PATHOPHYSIOLOGICAL; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PLGA MICROPARTICLES; POLY(LACTIC-CO-GLYCOLIC ACID); PROLIFERATION RATE; REPLICATIVE SENESCENCE; SMALL INTERFERING RNA; SMALL INTERFERING RNA (SIRNA); STEROID HORMONE; TISSUE REGENERATION; UNDERLYING MECHANISM; UPREGULATED EXPRESSION;

RNA;

GLUCOCORTICOID RECEPTOR; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; SMALL INTERFERING RNA;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; LACTIC ACID; MESENCHYMAL STROMAL CELLS; POLYGLYCOLIC ACID; RECEPTORS, GLUCOCORTICOID; RNA, SMALL INTERFERING;

EID: 84859010492     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0432     Document Type: Article

References (46)

1. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
2. Barry, F.P., and Murphy, J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36, 568, 2004.
3. Mauney, J.R., Volloch, V., and Kaplan, D.L. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11, 787, 2005.
4. Bellantuono, I., Aldahmash, A., and Kassem, M. Aging of marrow stromal (skeletal) stem cells and their contribution to age-related bone loss. Biochim Biophys Acta 1792, 364, 2009.
5. Mueller, S.M., and Glowacki, J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 82, 583, 2001.
6. Roobrouck, V.D., Ulloa-Montoya, F., and Verfaillie, C.M. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res 314, 1937, 2008.
7. Rodríguez, J.P., Montecinos, L., Ríos, S., Reyes, P., and Martínez, J. Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem 79, 557, 2000.
8. Rodríguez, J.P., Ríos, S., Fernández, M., and Santibañ ez, J.F. Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women. J Cell Biochem 92, 745, 2004.
9. Vacanti, V., Kong, E., Suzuki, G., Sato, K., Canty, J.M., and Lee, T. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol 205, 194, 2005.
10. Baksh, D., Song, L., and Tuan, R.S. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8, 301, 2004.
11. Kolf, C.M., Cho, E., and Tuan, R.S. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9, 204, 2007.
12. Wessely, O., Deiner, E.M., Beug, H., and von Lindern, M. The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors. EMBO J 15, 267, 1997.
13. Ichiyoshi, H., Kiyozuka, Y., Kishimoto, Y., Fukuhara, S., and Tsubura, A. Massive telomere loss and telomerase RNA expression in dexamethasone-induced apoptosis in mouse thymocytes. Exp Mol Pathol 75, 178, 2003.
14. Wolkowitz, O.M., Epel, E.S., Reus, V.I., and Mellon, S.H. Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety 27, 327, 2010.
15. Lupien, S.J., Schwartz, G., Ng, Y.K., Fiocco, A., Wan, N., Pruessner, J.C., Meaney, M.J., and Nair, N.P. The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings. J Psychiatry Neurosci 30, 328, 2005.
16. Matthews, S.G., Owen, D., Banjanin, S., and Andrews, M.H. Glucocorticoids, hypothalamo-pituitary-adrenal (HPA) development, and life after birth. Endocr Res 28, 709, 2002.
17. Sah, D.W.Y., Bumcrot, D., Manoharan, M., and Koteliansky, V. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2, 711, 2006.
18. de Fougerolles, A., Vornlocher, H. P., Maraganore, J., and Lieberman, J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6, 443, 2007.
19. Zhang, S.B., Zhao, B., Jiang, H.M., Wang, B., and Ma, B.C. Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 123, 1, 2007.
20. Dowdy, S.F., and Meade, B.R. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev 60, 530, 2008.
21. Tseng, Y.C., Mozumdar, S., and Huang, L. Lipid-based systemic delivery of siRNA. Adv Drug Deliv Rev 61, 721, 2009.
22. Bala, I., Hariharan, S., and Kumar, M.N. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 21, 387, 2004.
23. Birnbaum, D.T., Kosmala, J.D., Henthorn, D.B., and Brannon-Peppas, L. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. J Control Release 3, 375, 2000.
24. Hong, L., Krishnamachari, Y., Seabold, D., Joshi, V., Schneider, G., and Salem, A.K. Intracellular release of 17-b estradiol from cationic polyamidoamine dendrimer surfacemodified poly (lactic-co-glycolic acid) microparticles improves osteogenic differentiation of human mesenchymal stromal cells. Tissue Eng Part C Methods 17, 319, 2011.
25. Kubo, H., Shimizu, M., Taya, Y., Kawamoto, T., Michida, M., Kaneko, E., Igarashi, A., Nishimura, M., Segoshi, K., Shimazu, Y., Tsuji, K., Aoba, T., and Kato, Y. Identification of mesenchymal stem cell (MSC)-transcription factors by microarray and knockdown analyses, and signature moleculemarked MSC in bone marrow by immunohistochemistry. Genes Cells 14, 407, 2009.
26. Larson, B.L., Ylostalo, J., Lee, R.H., Gregory, C., and Prockop, D.J. Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells. Tissue Eng Part A 16, 3385, 2010.
27. Tsiridis, E., Ali, Z., Bhalla, A., Gamie, Z., Heliotis, M., Gurav, N., Deb, S., and DiSilvio, L. In vitro proliferation and differentiation of human mesenchymal stem cells on hydroxyapatite versus human demineralised bone matrix with and without osteogenic protein-1. Expert Opin Biol Ther 9, 9, 2009.
28. Tsiridis, E., Ali, Z., Bhalla, A., Heliotis, M., Gurav, N., Deb, S., and DiSilvio, L. In vitro and in vivo optimization of impaction allografting by demineralization and addition of rh-OP-1. J Orthop Res 25, 1425, 2007.
29. Ivirico, J.L., Salmerón-Sánchez, M., Ribelles, J.L., Pradas, M.M., Soria, J.M., Gomes, M.E., Reis, R.L., and Mano, J.F. Proliferation and differentiation of goat bone marrow stromal cells in 3D scaffolds with tunable hydrophilicity. J Biomed Mater Res B Appl Biomater 91, 277, 2009.
30. Hong, L., Zhang, G., Sultana, H., Yu, Y., and Wei, Z. The effects of 17-b estradiol on enhancing proliferation of human bone marrow mesenchymal stromal cells in vitro. Stem Cells Dev 20, 925, 2011.
31. Moerman, E.J., Teng, K., Lipschitz, D.A., and Lecka-Czernik, B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 3, 379, 2004.
32. Kim, C.H., Cheng, S.L., and Kim, G.S. Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: possible mechanisms of glucocorticoid-induced bone loss. J Endocrinol 162, 371, 1999.
33. Walsh, S., Jordan, G.R., Jefferiss, C., Stewart, K., and Beresford, J.N. High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. Rheumatology (Oxford) 40, 74, 2001.
34. Dennis, J.E., Merriam, A., Awadallah, A., Yoo, J.U., Johnstone, B., and Caplan, A.I. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 14, 700, 1999.
35. Hanada,K.,Dennis, J.E., andCaplan,A.I. Stimulatory effects of basic fibroblast growth factor and bonemorphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 12, 1606, 1997.
36. Ito, T., Sawada, R., Fujiwara, Y., Seyama, Y., and Tsuchiya, T. FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. Biochem Biophys Res Commun 20, 108, 2007.
37. Dvorak, P., Dvorakova, D., and Hampl, A. Fibroblast growth factor signaling in embryonic and cancer stem cells. FEBS Lett 22, 2869, 2006.
38. Coutu, D.L., François, M., and Galipeau, J. Inhibition of cellular senescence by developmentally regulated FGFreceptors in mesenchymal stem cells. Blood 117, 6801, 2011.
39. Woodrow, K.A., Cu, Y., Booth, C.J., Saucier-Sawyer, J.K., Wood, M.J., and Saltzman, W.M. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater 8, 526, 2009.
40. Cun, D., Jensen, D.K., Maltesen, M.J., Bunker, M., Whiteside, P., Scurr, D., Foged, C., and Nielsen, H.M. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Eur J Pharm Biopharm 77, 26, 2011.
41. Mountziaris, P.M., Sing, D.C., Chew, S.A., Tzouanas, S.N., Lehman, E.D., Kasper, F.K., and Mikos, A.G. Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint. Pharm Res 28, 1370, 2011.
42. Brunner, T., Cohen, S., and Monsonego, A. Silencing of proinflammatory genes targeted to peritoneal-residing macrophages using siRNA encapsulated in biodegradable microspheres. Biomaterials 31, 2627, 2010.
43. Cun, D., Foged, C., Yang, M., Frøkjaer, S., and Nielsen, H.M. Preparation and characterization of poly(DL-lactide-coglycolide) nanoparticles for siRNA delivery. Int J Pharm 390, 70, 2010.
44. Braden, A.R., Kafka, M.T., Cunningham, L., Jones, H., and Vishwanatha, J.K. Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth. J Nanosci Nanotechnol 9, 2856, 2009.
45. Murata, N., Takashima, Y., Toyoshima, K., Yamamoto, M., and Okada, H. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. J Control Release 20, 246, 2008.
46. Nguyen, J., Steele, T.W., Merkel, O., Reul, R., and Kissel, T. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy. J Control Release 18, 243, 2008.